tiprankstipranks
Advertisement
Advertisement

HK:9926 Stock Latest News

Akeso Launches HK$200 Million Share Purchase as Leadership Boosts Stakes
Company AnnouncementsAkeso Launches HK$200 Million Share Purchase as Leadership Boosts Stakes
23h ago
Akeso’s AK104 Lung Cancer Trial Completion: What Investors Should Watch Next
PremiumCompany Announcements
Akeso’s AK104 Lung Cancer Trial Completion: What Investors Should Watch Next
1d ago
9926
Akeso Sets 2026 AGM to Approve Accounts, Board Slate and Capital-Issuance Mandate
PremiumCompany Announcements
Akeso Sets 2026 AGM to Approve Accounts, Board Slate and Capital-Issuance Mandate
7d ago
Akeso’s ivonescimab trial at ASCO plenary signals potential new lung cancer standard
PremiumCompany Announcements
Akeso’s ivonescimab trial at ASCO plenary signals potential new lung cancer standard
11d ago
Akeso: Robust FY25 Execution and Late‑Stage Oncology Pipeline Drive Upside and Higher Target Price
PremiumRatings
Akeso: Robust FY25 Execution and Late‑Stage Oncology Pipeline Drive Upside and Higher Target Price
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
RADX
SMMT
Summit Therapeutics to present multiple ivonescimab data sets at ELCC 2026
Premium
The Fly
Summit Therapeutics to present multiple ivonescimab data sets at ELCC 2026
3M ago
SMMT
Akeso Boosts Revenue and R&D While Trimming Adjusted EBITDA Loss in 2025
Premium
Company Announcements
Akeso Boosts Revenue and R&D While Trimming Adjusted EBITDA Loss in 2025
3M ago
Akeso Advances Dual-Antibody Cancer Trial, Keeping Oncology Pipeline in Focus
PremiumCompany Announcements
Akeso Advances Dual-Antibody Cancer Trial, Keeping Oncology Pipeline in Focus
3M ago
9926
Akeso’s AK120 Phase II Completion Adds New Momentum to Its Atopic Dermatitis Pipeline
PremiumCompany Announcements
Akeso’s AK120 Phase II Completion Adds New Momentum to Its Atopic Dermatitis Pipeline
3M ago
9926
Akeso Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Akeso Schedules Board Meeting to Approve 2025 Annual Results
3M ago
Akeso Advances AK112 Trial in Liver Cancer, Setting Up a New Catalyst for HK:9926
PremiumCompany Announcements
Akeso Advances AK112 Trial in Liver Cancer, Setting Up a New Catalyst for HK:9926
3M ago
9926
Akeso Completes Key Early-Stage Cancer Trial, Keeping Investor Focus on Pipeline Upside
PremiumCompany AnnouncementsAkeso Completes Key Early-Stage Cancer Trial, Keeping Investor Focus on Pipeline Upside
3M ago
9926
Akeso’s AK112 Lung Cancer Trial Reaches Completion: What Investors Should Watch Next
Premium
Company Announcements
Akeso’s AK112 Lung Cancer Trial Reaches Completion: What Investors Should Watch Next
3M ago
9926
Akeso Moves AK139 Into Phase II, Targeting Growth in Seasonal Allergy Market
Premium
Company Announcements
Akeso Moves AK139 Into Phase II, Targeting Growth in Seasonal Allergy Market
3M ago
9926
Akeso Advances New Asthma Biologic AK139 Into Phase II, Extending Its Respiratory Pipeline
PremiumCompany Announcements
Akeso Advances New Asthma Biologic AK139 Into Phase II, Extending Its Respiratory Pipeline
3M ago
9926
Akeso Advances AK104 Into Phase 3 Colon Cancer Trial, Signaling Long-Term Growth Potential
PremiumCompany Announcements
Akeso Advances AK104 Into Phase 3 Colon Cancer Trial, Signaling Long-Term Growth Potential
3M ago
9926
Akeso Grants JumpCan Exclusive Mainland China Rights to Cholesterol Drug 伊喜寧®
PremiumCompany Announcements
Akeso Grants JumpCan Exclusive Mainland China Rights to Cholesterol Drug 伊喜寧®
4M ago
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
PremiumCompany Announcements
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
5M ago
Akeso announces NMPA acceptance of second NDA for gumokimab
PremiumThe FlyAkeso announces NMPA acceptance of second NDA for gumokimab
5M ago
Akeso downgraded to Hold from Buy at Daiwa
Premium
The Fly
Akeso downgraded to Hold from Buy at Daiwa
5M ago
Akeso Restructures MAb Manufacturing Deal as Joint Venture Becomes Connected Transaction
Premium
Company Announcements
Akeso Restructures MAb Manufacturing Deal as Joint Venture Becomes Connected Transaction
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >